JCI Insight (Jun 2021)

Pdcd10-Stk24/25 complex controls kidney water reabsorption by regulating Aqp2 membrane targeting

  • Rui Wang,
  • Shi-Ting Wu,
  • Xi Yang,
  • Yude Qian,
  • Jaesung P. Choi,
  • Rui Gao,
  • Siliang Song,
  • Yixuan Wang,
  • Tao Zhuang,
  • Justin J.L. Wong,
  • Yuzhen Zhang,
  • Zhiming Han,
  • Hua A. Lu,
  • Stephen I. Alexander,
  • Renjing Liu,
  • Yin Xia,
  • Xiangjian Zheng

Journal volume & issue
Vol. 6, no. 12

Abstract

Read online

PDCD10, also known as CCM3, is a gene found to be associated with the human disease cerebral cavernous malformations (CCMs). PDCD10 forms a complex with GCKIII kinases including STK24, STK25, and MST4. Studies in C. elegans and Drosophila have shown a pivotal role of the PDCD10-GCKIII complex in maintaining epithelial integrity. Here, we found that mice deficient of Pdcd10 or Stk24/25 in the kidney tubules developed polyuria and displayed increased water consumption. Although the expression levels of aquaporin genes were not decreased, the levels of total and phosphorylated aquaporin 2 (Aqp2) protein in the apical membrane of tubular epithelial cells were decreased in Pdcd10- and Stk24/25-deficient mice. This loss of Aqp2 was associated with increased expression and membrane targeting of Ezrin and phosphorylated Ezrin, Radixin, Moesin (p-ERM) proteins and impaired intracellular vesicle trafficking. Treatment with Erlotinib, a tyrosine kinase inhibitor promoting exocytosis and inhibiting endocytosis, normalized the expression level and membrane abundance of Aqp2 protein, and partially rescued the water reabsorption defect observed in the Pdcd10-deficient mice. Our current study identified the PDCD10-STK-ERM signaling pathway as a potentially novel pathway required for water balance control by regulating vesicle trafficking and protein abundance of AQP2 in the kidneys.

Keywords